EPRezeptoren

EPRezeptoren, also known as prostaglandin E receptors, are a family of G protein-coupled receptors involved in a wide range of physiological processes. There are four known subtypes: EP1, EP2, EP3, and EP4. These receptors are activated by prostaglandin E2 (PGE2), a potent lipid mediator derived from arachidonic acid.

The EP receptors are expressed in various tissues throughout the body, including the cardiovascular system, nervous system, gastrointestinal tract, kidneys, and reproductive organs. Their diverse distribution contributes to their broad range of functions.

Activation of EP receptors leads to different intracellular signaling cascades depending on the receptor subtype and the cell type. For example, EP1 receptors are typically coupled to Gq proteins, leading to an increase in intracellular calcium. EP2 and EP4 receptors are primarily coupled to Gs proteins, which activate adenylyl cyclase and increase cyclic AMP levels. EP3 receptors can be coupled to Gi proteins, inhibiting adenylyl cyclase and decreasing cyclic AMP, but can also couple to Gs or Gq in certain contexts.

The physiological effects mediated by EP receptors are numerous and include regulation of blood pressure, inflammation, pain perception, gastric acid secretion, uterine contractions, and kidney function. Due to their involvement in various disease states, including cancer, inflammatory disorders, and cardiovascular diseases, EP receptors are considered important therapeutic targets. Research continues to explore the specific roles of each EP receptor subtype and their potential for pharmacological intervention.